ArticleFrontiers in pharmacology2017

Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts.

Daniela Gentile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.